Trial of Controversial Alzheimer’s Drug Halted After Disappointing ...
5 days ago · Cassava Sciences, a small biotechnology company based in Austin, Texas, announced it would stop the advanced clinical trial for an experimental Alzheimer’s drug, …
Cassava Sciences and its Alzheimer's drug are done. The damage …
5 days ago · The Cassava Sciences story ended Monday exactly as many knew it would — with the company’s experimental drug for Alzheimer’s disease, simufilam, failing a clinical trial.
Cassava Sciences Topline Phase 3 Data Did Not Meet Co-Primary …
5 days ago · AUSTIN, Texas, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a clinical-stage biotechnology company …
Cassava Sciences' stock craters after Alzheimer's disease trial fails ...
5 days ago · News is the latest setback for the clinical-stage biotech, which was the subject of SEC and Justice Department investigations earlier this year Cassava Sciences Inc.'s stock …
Cassava Sciences Topline Phase 3 Data Did Not Meet Co-Primary …
5 days ago · AUSTIN, Texas, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a clinical-stage biotechnology company …
Cassava Sciences, Inc. (SAVA) Latest Stock News & Headlines
Get the latest Cassava Sciences, Inc. (SAVA) stock news and headlines to help you in your trading and investing decisions.
PRESS RELEASES - Cassava Sciences, Inc.
AUSTIN, Texas , Sept. 26, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (“Cassava” or the “Company”) (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, …
Cassava Sciences, Inc. (SAVA) Stock Price, News, Quote & History ...
Find the latest Cassava Sciences, Inc. (SAVA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Cassava Sciences Resolves SEC Investigation
Sep 26, 2024 · Cassava, without admitting or denying the SEC’s allegations, agreed to pay a monetary penalty of $40 million. The Company cooperated fully with the SEC’s investigation …
Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug
Jul 18, 2024 · Two top officials at Cassava Sciences — a small pharmaceutical company in Austin, Texas, embroiled in years of controversy over a proposed Alzheimer’s drug — have …